Clinical trial
Effectiveness of Clopidogrel Resinate(PRegrel®) in Patients Undergoing Percutaneous Coronary Intervention Compared With ClopiDogrEl Bisulfate(Plavix®)
NCT01349777 is registered in ClinicalTrials.gov with Seung-Jung Park as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness of Clopidogrel Resinate(PRegrel®) in Patients Undergoing Percutaneous Coronary Intervention Compared With ClopiDogrEl Bisulfate(Plavix®)
- Lead sponsor
- Seung-Jung Park
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 15, 2010
- Completion date
- March 14, 2017
- Enrollment
- 1,056 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.